Literature DB >> 28263287

A severe umbilical cord stem cell infusion reaction due to dextran in an atopic pediatric patient.

L Cooling1, A Sankar2, R Mody2, G Yanik2, C Bonifant2, S W Choi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28263287     DOI： 10.1038/bmt.2017.33

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment.

Authors:  T Hahn; U Bunworasate; M C George; A S Bir; W Chinratanalab; A R Alam; B Bambach; M R Baer; J L Slack; M Wetzler; J L Becker; P L McCarthy
Journal:  Bone Marrow Transplant       Date:  2003-07       Impact factor: 5.483

2.  Coronary artery spasm after infusion of cryopreserved cord blood cells.

Authors:  A D Petropoulou; R Bellochine; F Norol; J-P Marie; B Rio
Journal:  Bone Marrow Transplant       Date:  2007-06-18       Impact factor: 5.483

Review 3.  Dextran 40 therapy made safer by pretreatment with dextran 1.

Authors:  Karl-Gösta Ljungström
Journal:  Plast Reconstr Surg       Date:  2007-07       Impact factor: 4.730

4.  Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004.

Authors:  Craig E Zinderman; Laurence Landow; Robert P Wise
Journal:  J Vasc Surg       Date:  2006-04-05       Impact factor: 4.268

5.  Another case of acute cardiopulmonary toxicity with cord blood infusion: is dextran the culprit?

Authors:  Sung Choi; Sandra Hoffmann; Laura Cooling
Journal:  Transfusion       Date:  2012-01       Impact factor: 3.157

6.  How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions.

Authors:  Ronit Reich-Slotky; Lohith S Bachegowda; Michael Ancharski; Lyubov Mendeleyeva; Pablo Rubinstein; Hanna Rennert; Tsiporah Shore; Koen van Besien; Melissa Cushing
Journal:  Transfusion       Date:  2015-02-05       Impact factor: 3.157

7.  Acute life-threatening cardiovascular toxicity with umbilical cord blood infusion: the role of dextran.

Authors:  Robert W Ma; John M Kwan; David D Ma; Keith C Fay
Journal:  Am J Hematol       Date:  2010-09       Impact factor: 10.047

Review 8.  Risks associated with transfusion of cellular blood components in Canada.

Authors:  Steven Kleinman; Penny Chan; Pierre Robillard
Journal:  Transfus Med Rev       Date:  2003-04

9.  A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.

Authors:  Juliet N Barker; Michelle Abboud; Robert D Rice; Rebecca Hawke; Allison Schaible; Glenn Heller; Vincent La Russa; Andromachi Scaradavou
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-25       Impact factor: 5.742

10.  An alternative to dextran for the thawing of cord blood units.

Authors:  Marc Cloutier; Carl Simard; Christine Jobin; Diane Fournier; Sonia Néron
Journal:  Transfusion       Date:  2016-05-03       Impact factor: 3.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.